Carnot AP-HP


Carnot AP HP relies on AP-HP, the first University Hospital Center in Europe, to structure a center to accelerate partnership research with companies engaged in innovation. Carnot AP HP has renowned experts, a comprehensive research and development ecosystem, as well as a governance that is committed to deadlines allowing short and agile processes. Carnot AP HP is offering industrial players solutions in applied and clinical research across the entire healthcare spectrum.

Key figures

Key figures

Permanent staff (full-time equivalent) 3370
PhD Students 1290
Global budget 90 M€
Partnership incomes with industry 42,5 M€


Institut Carnot AP-HP
Direction de la Recherche Clinique et de l’Innovation (DRCI) de l’AP-HP
Carré Historique de l’Hôpital Saint-Louis, porte 23
1, avenue Claude Vellefaux
75475 PARIS Cedex 10

Email contact
Parent institutions


Key player in health research in Europe

  • 1st University hospital (10 million patients/year)
  • 7.5 billion Euros annual budget
  • 1st clinical trials promoter in Europe
  • 10% of public hospitalization in France
  • 40% of clinical research in France
  • 8,390 publications of which 24% ranked A in 2018

Orientation towards Partnership Research

  • 320 R&D contracts in 2019, including 62 partnership research with an industrial partner
  • 653 patent portfolios (1/3 already licensed)
  • 10% of public valorization revenue in France (24M Euros in 2019)
  • 17 drugs and medical devices on the market:
    • 3 Marketing Authorizations since 2018,
    • 2 Marketing Authorizations in progress (FDA)

Clinical Studies and Translational Research Solutions

  • Feasibility studies and clinical trials set up
  • Clinical and medico-economic evaluation of medical devices
  • e-cohort and real-life study
  • Pharmaceutical development
  • Algorithms development

The Value share of Carnot AP HP

  • European leader in clinical and translational research
  • Renowned experts in all specialties
  • Complete ecosystem (1st European health data warehouse, registers, cohorts, biological collections, research platforms, etc.) and connected to its partners
  • A dedicated structure and governance integrating industrial partners with performance commitments (deadlines)
  • A new institute to complement the other Carnots

Technological platforms:

  • The Pharmaceutical R&D Department (General Agency for Equipment & Health Products AGEPS)
  • The AP-HP Health Data Warehouse (EDS)
  • MEARY, the production center for Medicines for Innovative Therapies
  • APHP’s Biobank for Intestinal Microbiota Research (BARM)
  • AP-HP Pharmacoepidemiology Center (CEPHEPI)
  • Digital Medical Hub (DMH) - Scientific evaluation of connected objects
  • The innovative Biomarkers platform
  • SeqOIA, the genomics platform
  • MOABI, for bioinformatics analysis for diagnostic purposes
  • ComPare, the platform for e-cohorts
  • Lumière for antenatal diagnosis
  • The Human Nutrition Research Center (CRNH)

Addressed Markets

  • Healthcare technologies: Medical devices, e-health and connected devices
  • Medicines: from molecules repositioning to gene and cell therapy
  • Pre-clinical research
  • Clinical study
  • Biotechnology
  • Diagnosis
  • Processing of health data
  • Artificial Intelligence